Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).
Carlos Abril-PérezMansilla-Polo MiguelBegoña Escutia-MuñozOnofre SanmartínJoan R GarcésManuel A Rodríguez-PrietoVerónica Ruiz-SalasEsther de Eusebio-MurilloRomán Miñano-MedranoBeatriz González-SixtoJuan L Artola-IgarzaAlberto Alfaro-RubioPedro Redondo BellónYolanda Delgado-JiménezJulia M Sánchez-SchmidtIrati Allende-MarkixanaMaría L Alonso-PachecoBeatriz García-BracamontePablo de la Cueva-DobaoRaquel Navarro-TejedorCristina Ciudad-BlancoLucía Carnero-GonzálezHugo Vázquez-VeigaNatividad Cano-MartínezCarlos Serra-GuillénEva VilarrasaPedro Sánchez-SambucetyJosé L López-EstebaranzÁngeles Flórez-MenéndezAntonio Martorell-CalatayudPilar GilVictoriano Morales-GordilloAgustín TollIzascun Ocerin-GuerraMatías Mayor-ArenalRicardo Suárez-FernándezLaura Sainz-GasparMiguel A DescalzoIgnacio Garcia-DovalRafael Botella-Estradanull nullPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
This study suggests that IS patients may be at a higher risk of development of AE such as bleeding or tumour necrosis and are at a higher risk of tumour recurrence. Close follow-up and consideration of the specific characteristics of NMSC in IS patients are crucial. Further research with extended follow-up is needed to better understand the long-term outcomes for this patient group.